期刊文献+
共找到1,399篇文章
< 1 2 70 >
每页显示 20 50 100
Surgical techniques and postoperative management to prevent postoperative pancreatic fistula after pancreatic surgery 被引量:49
1
作者 Hiromichi Kawaida Hiroshi Kono +4 位作者 Naohiro Hosomura Hidetake Amemiya Jun Itakura Hideki Fujii Daisuke Ichikawa 《World Journal of Gastroenterology》 SCIE CAS 2019年第28期3722-3737,共16页
Postoperative pancreatic fistula (POPF) is one of the most severe complications after pancreatic surgeries. POPF develops as a consequence of pancreatic juice leakage from a surgically exfoliated surface and/or anasto... Postoperative pancreatic fistula (POPF) is one of the most severe complications after pancreatic surgeries. POPF develops as a consequence of pancreatic juice leakage from a surgically exfoliated surface and/or anastomotic stump, which sometimes cause intraperitoneal abscesses and subsequent lethal hemorrhage. In recent years, various surgical and perioperative attempts have been examined to reduce the incidence of POPF. We reviewed several well-designed studies addressing POPF-related factors, such as reconstruction methods, anastomotic techniques, stent usage, prophylactic intra-abdominal drainage, and somatostatin analogs, after pancreaticoduodenectomy and distal pancreatectomy, and we assessed the current status of POPF. In addition, we also discussed the current status of POPF in minimally invasive surgeries, laparoscopic surgeries, and robotic surgeries. 展开更多
关键词 POSTOPERATIVE pancreatic fistula PANCREATICODUODENECTOMY Pancreatojejunostomy PANCREATOGASTROSTOMY Distal PANCREATECTOMY prophylactic drainage SOMATOSTATIN analogs
下载PDF
Present and future of prophylactic antibiotics for severe acute pancreatitis 被引量:39
2
作者 Kun Jiang Wei Huang +1 位作者 Xiao-Nan Yang Qing xia 《World Journal of Gastroenterology》 SCIE CAS CSCD 2012年第3期279-284,共6页
AIM: To investigate the role of prophylactic antibiotics in the reduction of mortality of severe acute pancreatitis (SAP) patients, which is highly questioned by more and more randomized controlled trials (RCTs) and m... AIM: To investigate the role of prophylactic antibiotics in the reduction of mortality of severe acute pancreatitis (SAP) patients, which is highly questioned by more and more randomized controlled trials (RCTs) and metaanalyses. METHODS: An updated meta-analysis was performed. RCTs comparing prophylactic antibiotics for SAP with control or placebo were included for meta-analysis. The mortality outcomes were pooled for estimation, and re-pooled estimation was performed by the sensitivity analysis of an ideal large-scale RCT. RESULTS: Currently available 11 RCTs were included. Subgroup analysis showed that there was significant reduction of mortality rate in the period before 2000, while no significant reduction in the period from 2000 [Risk Ratio, (RR ) = 1.01, P = 0.98]. Funnel plot indi-cated that there might be apparent publication bias in the period before 2000. Sensitivity analysis showed that the RR of mortality rate ranged from 0.77 to 1.00 with a relatively narrow confidence interval (P < 0.05). However, the number needed to treat having a minor lower limit of the range (7-5096 patients) implied that certain SAP patients could still potentially prevent death by antibiotic prophylaxis. CONCLUSION: Current evidences do not support prophylactic antibiotics as a routine treatment for SAP, but the potentially benefited sub-population requires further investigations. 展开更多
关键词 Severe acute pancreatitis prophylactic antibiotics Mortality Meta-analysis
下载PDF
骨科Ⅰ类切口手术抗菌药物预防使用干预效果研究 被引量:35
3
作者 卓霞 阚燕 闽鹏 《中国抗生素杂志》 CAS CSCD 北大核心 2013年第10期799-800,I0001,I0002,共4页
目的比较国家“限抗令”政策下,我院骨科在采取抗菌药物干预措施后,I类切口手术预防性抗菌药物使用状况的变化。方法回顾性分析本院骨科2010年7—2012月7月收治的的2288例I类切口手术患者病历,并按照医院进行抗菌药专项整治活动时点... 目的比较国家“限抗令”政策下,我院骨科在采取抗菌药物干预措施后,I类切口手术预防性抗菌药物使用状况的变化。方法回顾性分析本院骨科2010年7—2012月7月收治的的2288例I类切口手术患者病历,并按照医院进行抗菌药专项整治活动时点将病例分为两组:2010.7—2011.7为治理前组(A组),2011.8—2012.7为治理后组(B组)。比较两组预防性抗菌药物使用率、抗菌药物品种、用药时机、用药疗程及联合用药情况。结果共收集合格病例2188份,其中A组1135份,B组1053份。在A和B组中有人工植入物的手术比例分别为46.3%和61.4%。A组和B组I类切口手术预防性抗菌药物使用率分别为89.8%和65.0%,其中无植入物手术的使用率分别为81.O%和15.5%。有植入物手术中,A组与B组用药品种合理率分别为48.4%和79.5%,无植入物手术中,A组与B组品种合理率分别为28.7%和46.2%。术前0.5—2h内预防用药比例在A和B组分别75%和80%,A和B组平均用药时间分别为6.8±2.6d和2.6±1.3d;A和B组联合用药率分别为11.2%和1_3%。统计学分析,A和B组相比,I类切口手术预防性抗菌药物使用率、用药品种合理率、用药时机、用药疗程、联合用药比例5方面都存在统计学差异‘P〈0.05)。结论我院在抗菌药物整治后,骨科I类切口手术的预防性用药有一定改善,但因近1年来有人工植入物的手术比例大,抗菌药的使用率和疗程与国家标准存在差距,有待进一步改进。 展开更多
关键词 骨科 I类切口 预防性用药 抗菌药物
下载PDF
肝硬化上消化道出血医院感染患者预防性应用抗菌药物的观察 被引量:31
4
作者 朱伟青 陈芝兰 黎红光 《中华医院感染学杂志》 CAS CSCD 北大核心 2011年第11期2317-2319,共3页
目的探讨预防性应用抗菌药物对肝硬化上消化道出血患者医院感染的影响和安全性。方法将100例患者随机分成观察组和对照组,各50例,观察组预防性应用抗菌药物,对照组不用抗菌药物,观察比较两组患者医院感染率、再出血率和住院时间等。结... 目的探讨预防性应用抗菌药物对肝硬化上消化道出血患者医院感染的影响和安全性。方法将100例患者随机分成观察组和对照组,各50例,观察组预防性应用抗菌药物,对照组不用抗菌药物,观察比较两组患者医院感染率、再出血率和住院时间等。结果观察组患者医院感染率为14.0%,再出血率为24.0%,住院时间(15.4±3.1)d,明显好于对照组,其医院感染率、再出血率及住院时间分别为38.0%、46.0%及(20.4±4.3)d,差异有统计学意义(P<0.05)。结论肝硬化上消化道出血患者预防性应用抗菌药物,可以降低医院感染率和再次出血率,缩短住院时间,值得临床推广应用。 展开更多
关键词 抗菌药物 预防性 医院感染 肝硬化 上消化道出血
原文传递
Hyperthermic intraperitoneal chemotherapy for gastric and colorectal cancer in China's Mainland 被引量:18
5
作者 Tao Suo Haile Mahteme Xin-Yu Qin 《World Journal of Gastroenterology》 SCIE CAS CSCD 2011年第8期1071-1075,共5页
AIM:To investigate the current status of peritoneal carcinomatosis(PC) management,as well as the usage of cytoreductive surgery(CRS) and hyperthermic intraperitoneal chemotherapy(HIPEC) in China's Mainland.METHODS... AIM:To investigate the current status of peritoneal carcinomatosis(PC) management,as well as the usage of cytoreductive surgery(CRS) and hyperthermic intraperitoneal chemotherapy(HIPEC) in China's Mainland.METHODS:A potentially curative therapeutic strategy for selecting patients with PC,known as "Techniques",consists of CRS in combination with HIPEC.A systemic search of published works and clinical trials was performed.Additional papers were retrieved by crosschecking references and obtaining information from Chinese oncologists and relevant conferences.One hundred and one papers and one registered clinical trial on HIPEC were included.RESULTS:A literature review identified 86 hospitals in 25 out of all 31 areas of China's Mainland that perform HIPEC.The earliest report included in our survey was published in 1993.Different approaches to HIPEC have been utilized,i.e.palliative,prophylactic,and possiblycurative treatment.Only one center has consistently performed HIPEC according to the "Sugarbaker Protocol",which involves evaluating the extent of PC with peritoneal cancer index and the results of CRS with the completeness of cytoreduction.Positive preliminary results were reported:7 of 21 patients with PC survived,free of tumors,during an 8-43-mo follow-up period.Hyperthermic strategies that include HIPEC have been practiced for a long time in China's Mainland,whereas the "Sugarbaker Protocol/Techniques" has been only rarely implemented in China.The Peritoneal Surface Oncology Group International hosts a biannual workshop with the intent to train more specialists in this field and provide support for the construction of quality treatment centers,especially in developing countries like China,whose population is huge and has a dramatically increased incidence of cancer.CONCLUSION:To popularize Sugarbaker Protocol/Techniques in China's Mainland in PC management arising from gastric cancer or colorectal cancer will be the responsibility of the upcoming Chinese Peritoneal Surface Oncology Group. 展开更多
关键词 Peritoneal carcinomatosis HYPERTHERMIA prophylactic strategy Sugarbaker Protocol/techniques China's Mainland
下载PDF
PDCA循环干预眼科Ⅰ类切口手术预防用抗菌药物使用的效果评价 被引量:16
6
作者 郭未艳 吕娟 +3 位作者 王园姬 王颖丽 王丹 李亚美 《中国医药导刊》 2020年第4期270-274,共5页
目的:分析PDCA循环干预我院眼科Ⅰ类切口手术预防用抗菌药物使用的效果。方法:采用回顾性分析法,随机抽取我院眼科PDCA循环干预前757例(2018年1~4月)、第1轮PDCA循环干预后853例(2018年5~8月)和第2轮PDCA循环干预后847例(2018年9~12月)... 目的:分析PDCA循环干预我院眼科Ⅰ类切口手术预防用抗菌药物使用的效果。方法:采用回顾性分析法,随机抽取我院眼科PDCA循环干预前757例(2018年1~4月)、第1轮PDCA循环干预后853例(2018年5~8月)和第2轮PDCA循环干预后847例(2018年9~12月)Ⅰ类切口手术患者出院病历,并对比分析抗菌药物预防应用情况。结果:经过2轮PDCA循环干预后,眼科Ⅰ类切口手术预防用抗菌药物使用率、给药途径不适宜率分别由23.9%、16.7%降低至11.2%、8.4%;选药合理率、给药时机合理率、疗程合理率分别由干预前的77.9%、17.7%和30.4%提高至第2轮干预后的89.5%、66.7%和70.5%,差异均有统计学意义(P<0.05)。结论:PDCA循环干预显著提高了我院眼科Ⅰ类切口手术预防用抗菌药物的使用合理率。 展开更多
关键词 PDCA循环 眼科 Ⅰ类切口手术 抗菌药物 预防用药
下载PDF
Predictive factors for central lymph node metastases in papillary thyroid microcarcinoma 被引量:16
7
作者 Xin Wu Bing-Lu Li +1 位作者 Chao-Ji Zheng Xiao-Dong He 《World Journal of Clinical Cases》 SCIE 2020年第8期1350-1360,共11页
Papillary thyroid microcarcinoma(PTMC)measures 1 cm or less in its longest dimension.The incidence of PTMC is increasing worldwide.Surgery is the primary treatment;however,prophylactic central lymph node dissection is... Papillary thyroid microcarcinoma(PTMC)measures 1 cm or less in its longest dimension.The incidence of PTMC is increasing worldwide.Surgery is the primary treatment;however,prophylactic central lymph node dissection is controversial,and discrepancies between different guidelines have been noted.Routine prophylactic central lymph node dissection may result in hypoparathyroidism and recurrent laryngeal nerve injury in some patients without lymph node metastasis,while simple thyroidectomy may leave metastatic lymph nodes in high-risk patients.To selectively perform prophylactic lymph node dissections in high-risk patients,it is important to identify predictive factors for lymph node metastases in patients with PTMC.Several studies have reported on this,but their conclusions are not entirely consistent.Several clinicopathologic characteristics have been identified as risk factors for central lymph node metastases,and the most commonly reported factors include age,gender,tumor size and location,multifocality,bilaterality,extrathyroidal extension,and abnormal lymph node found using ultrasound.Here,we provide an overview of previous studies along with a favorable opinion on or against these factors,with the aim of increasing the understanding of this topic among the medical community.In addition,current opinions about prophylactic central lymph node dissection are reviewed and discussed. 展开更多
关键词 PAPILLARY THYROID carcinoma PAPILLARY THYROID MICROCARCINOMA CENTRAL LYMPH node dissection prophylactic Risk factor Prognosis
下载PDF
五水头孢唑啉钠对比头孢唑啉钠在预防性和治疗性用药中的有效性和安全性的系统评价 被引量:15
8
作者 刘记 李自华 +2 位作者 高慧玲 朱亚申 秦向斐 《中国药房》 CAS CSCD 2013年第40期3797-3800,共4页
目的:系统评价五水头孢唑啉钠对比头孢唑啉钠在预防性和治疗性用药中的有效性和安全性。方法:计算机检索中国期刊全文数据库、维普数据库、万方数字化期刊全文数据库、中国生物医学文献数据库、PubMed,纳入五水头孢唑啉钠对比头孢唑啉... 目的:系统评价五水头孢唑啉钠对比头孢唑啉钠在预防性和治疗性用药中的有效性和安全性。方法:计算机检索中国期刊全文数据库、维普数据库、万方数字化期刊全文数据库、中国生物医学文献数据库、PubMed,纳入五水头孢唑啉钠对比头孢唑啉钠在预防性和治疗性用药中的有效性和安全性的随机对照试验(RCT),采用Rev Man 5.0统计学软件进行Meta分析。结果:共纳入14项RCT,其中预防性用药4项,合计739例患者;治疗性用药10项,合计976例患者。Meta分析结果显示,预防性应用五水头孢唑啉钠在术后切口感染发生率[OR=0.40,95%CI(0.15,1.10),P=0.07]和有效率[OR=4.02,95%CI(0.97,16.61),P=0.05]方面与头孢唑啉钠比较差异均无统计学意义;五水头孢唑啉钠治疗细菌感染的临床有效率显著高于头孢唑啉钠[OR=3.24,95%CI(2.06,5.10),P<0.01],但细菌清除率与头孢唑啉钠比较差异无统计学意义[OR=1.75,95%CI(0.75,4.09),P=0.20];五水头孢唑啉钠的不良反应发生率低于头孢唑啉钠[OR=0.52,95%CI(0.29,0.93),P=0.03],两组比较差异有统计学意义。结论:五水头孢唑啉钠在预防性用药方面的疗效与头孢唑啉钠相似,但在治疗性用药方面的疗效优于头孢唑啉钠,且前者安全性优于后者。 展开更多
关键词 五水头孢唑啉钠 头孢唑啉钠 预防 治疗 META分析
原文传递
Surgical specimen extraction via a prophylactic ileostomy procedure: A minimally invasive technique for laparoscopic rectal cancer surgery 被引量:12
9
作者 Peng Wang Jian-Wei Liang +2 位作者 Hai-Tao Zhou Zheng Wang Zhi-Xiang Zhou 《World Journal of Gastroenterology》 SCIE CAS 2018年第1期104-111,共8页
AIM To retrospectively evaluate the safety and feasibility of surgical specimen extraction via a prophylactic ileostomy procedure in patient with rectal cancer. METHODS We systematically reviewed 331 consecutive patie... AIM To retrospectively evaluate the safety and feasibility of surgical specimen extraction via a prophylactic ileostomy procedure in patient with rectal cancer. METHODS We systematically reviewed 331 consecutive patients who underwent laparoscopic anterior resection for rectal cancer and prophylactic ileostomy in our institution from June 2010 to October 2016, including 155 patients who underwent specimen extraction via a prophylactic ileostomy procedure(experimental group), and 176 patients who underwent specimen extraction via a small lower abdominal incision(control group). Clinical data were collected from both groups andstatistically analyzed. RESULTS The two groups were matched in clinical characteristics and pathological outcomes. However, mean operative time was significantly shorter in the experimental group compared to the control group(161.3 ± 21.5 min vs 168.8 ± 20.5 min; P = 0.001). Mean estimated blood loss was significantly less in the experimental group(77.4 ± 30.7 mL vs 85.9 ± 35.5 mL; P = 0.020). The pain reported by patients during the first two days after surgery was significantly less in the experimental group than in the control group. No wound infections occurred in the experimental group, but 4.0% of the controls developed wound infections(P = 0.016). The estimated 5-year disease-free survival and overall survival rate were similar between the two groups.CONCLUSION Surgical specimen extraction via a prophylactic ileostomy procedure represents a secure and feasible approach to laparoscopic rectal cancer surgery, and embodies the principle of minimally invasive surgery. 展开更多
关键词 MINIMALLY INVASIVE surgery RECTAL cancer Anastomotic leakage prophylactic ILEOSTOMY Safety
下载PDF
A novel human mAb (MERS-GD27) provides prophylactic and postexposure efficacy in MERS-CoV susceptible mice 被引量:14
10
作者 Peihua Niu Guangyu Zhao +4 位作者 Yao Deng Shihui Sun Wenling Wang Yusen Zhou Wenjie Tan 《Science China(Life Sciences)》 SCIE CAS CSCD 2018年第10期1280-1282,共3页
Dear Editor,Since September 2012, the Middle East respiratory syndrome coronavirus (MERS-CoV) cases have been reported in more than 27 countries, and more than 2,000 cases have been confirmed in the laboratory (http:/... Dear Editor,Since September 2012, the Middle East respiratory syndrome coronavirus (MERS-CoV) cases have been reported in more than 27 countries, and more than 2,000 cases have been confirmed in the laboratory (http://www.who.int/emergencies/mers-cov/en/). MERS-CoV causes an acute and severe respiratory illness with a high mortality rate(~35%) in humans (Shi et al., 2017, Zaki et al., 2012).Neutralizing antibodies targeting the spike of MERS-CoV have been shown to be a therapeutic option for treatment of lethal disease (Agrawal et al., 2016, Ying et al., 2014). 展开更多
关键词 provides prophylactic and postexposure efficacy in MERS-CoV susceptible mice A novel human mAb MERS-GD27 Figure DPP
原文传递
Analysis of the risk factors for severity in post endoscopic retrograde cholangiopancreatography pancreatitis: The indication of prophylactic treatments 被引量:14
11
作者 Hiroshi Matsubara Fumihiro Urano +4 位作者 Yuki Kinoshita Shozo Okamura Hiroki Kawashima Hidemi Goto Yoshiki Hirooka 《World Journal of Gastrointestinal Endoscopy》 CAS 2017年第4期189-195,共7页
To determine the risk factors of severe post endoscopic retrograde cholangiopancreatography pancreatitis (sPEP) and clarify the indication of prophylactic treatments. METHODSAt our hospital, endoscopic retrograde chol... To determine the risk factors of severe post endoscopic retrograde cholangiopancreatography pancreatitis (sPEP) and clarify the indication of prophylactic treatments. METHODSAt our hospital, endoscopic retrograde cholangiopancreatography (ERCP) was performed on 1507 patients from May 2012 to December 2015. Of these patients, we enrolled all 121 patients that were diagnosed with post endoscopic retrograde PEP. Fourteen of 121 patients diagnosed as sPEP were analyzed. RESULTSForty-one patients had contrast media remaining in the pancreatic duct after completion of ERCP. Seventy-one patients had abdominal pain within three hours after ERCP. These were significant differences for sPEP (P < 0.05). The median of Body mass index, the median time for ERCP, the median serum amylase level of the next day, past histories including drinking and smoking, past history of pancreatitis, sphincter of Oddi dysfunction, whether emergency or not, expertise of ERCP procedure, diverticulum nearby Vater papilla, whether there was sphincterotomy or papillary balloon dilation, pancreatic duct cannulation, use of intra-ductal ultrasonography enforcement, and transpapillary biopsies had no significant differences with sPEP. CONCLUSIONContrast media remaining in the pancreatic duct and the appearance of abdominal pain within three hours after ERCP were risk factors of sPEP. 展开更多
关键词 Pancreatic duct stent Post endoscopic retrograde cholangiopancreatography pancreatitis prophylactic treatment Risk factor Severe acute pancreatitis
下载PDF
剖宫产术预防性使用抗菌药物的临床研究 被引量:14
12
作者 刘仕英 王光花 王颖懿 《实用药物与临床》 CAS 2010年第5期337-338,共2页
目的探讨不同的抗菌药物使用方式在剖宫产术中预防感染的临床效果。方法将120例择期剖宫产孕妇随机分为2组:研究组60例,术前30 min静脉滴注头孢呋辛1.5 g、甲硝唑0.5 g,术后相同剂量2次/d,连用1~2 d;对照组60例,术前不用药,术后同样药... 目的探讨不同的抗菌药物使用方式在剖宫产术中预防感染的临床效果。方法将120例择期剖宫产孕妇随机分为2组:研究组60例,术前30 min静脉滴注头孢呋辛1.5 g、甲硝唑0.5 g,术后相同剂量2次/d,连用1~2 d;对照组60例,术前不用药,术后同样药物、相同剂量和方法连用3~5 d。结果两组术后发病率、发热发生率、术后感染发生率、术后白细胞升高差异均无统计学意义(P>0.05);但术后住院天数和抗菌药物费用研究组明显低于对照组(P<0.05)。结论围手术期应用抗菌药物是预防剖宫产术后感染的有效方法,术前30 min给药,短程应用更加合理。 展开更多
关键词 剖宫产 抗菌药物 预防 感染
下载PDF
Prevention and management of hepatitis B virus reactivation in patients with hematological malignancies treated with anticancer therapy 被引量:14
13
作者 Man Fai Law Rita Ho +8 位作者 Carmen KM Cheung Lydia HP Tam Karen Ma Kent CY So Bonaventure Ip Jacqueline So Jennifer Lai Joyce Ng Tommy HC Tam 《World Journal of Gastroenterology》 SCIE CAS 2016年第28期6484-6500,共17页
Hepatitis due to hepatitis B virus(HBV) reactivation can be severe and potentially fatal, but is preventable. HBV reactivation is most commonly reported in patients receiving cancer chemotherapy, especially rituximabc... Hepatitis due to hepatitis B virus(HBV) reactivation can be severe and potentially fatal, but is preventable. HBV reactivation is most commonly reported in patients receiving cancer chemotherapy, especially rituximabcontaining therapy for hematological malignancies and those receiving stem cell transplantation. All patients with hematological malignancies receiving anticancer therapy should be screened for active or resolved HBV infection by blood tests for hepatitis B surface antigen(HBs Ag) and antibody to hepatitis B core antigen(antiHBc). Patients found to be positive for HBs Ag should be given prophylactic antiviral therapy to prevent HBV reactivation. For patients with resolved HBV infection, no standard strategy has yet been established to prevent HBV reactivation. There are usually two options. One is pre-emptive therapy guided by serial HBV DNA monitoring, whereby antiviral therapy is given as soon as HBV DNA becomes detectable. However, there is little evidence regarding the optimal interval and period of monitoring. An alternative approach is prophylactic antiviral therapy, especially for patients receiving highrisk therapy such as rituximab, newer generation of anti-CD20 monoclonal antibody, obinutuzumab or hematopoietic stem cell transplantation. This strategy may effectively prevent HBV reactivation and avoid the inconvenience of repeated HBV DNA monitoring. Entecavir or tenofovir are preferred over lamivudine as prophylactic therapy. Although there is no well-defined guideline on the optimal duration of prophylactic therapy, there is growing evidence to recommend continuing prophylactic antiviral therapy for at least 12 mo after cessation of chemotherapy, and even longer for those who receive rituximab or who had high serum HBV DNA levels before the start of immunosuppressive therapy. Many novel agents have recently become available for the treatment of hematological malignancies, and these agents may be associated with HBV reactivation. Although there is currently limited evidence to guide the opt 展开更多
关键词 Hepatitis B virus reactivation Hematological malignancies RITUXIMAB Hematopoietic stem cell transplant prophylactic antiviral therapy
下载PDF
预防性回肠造口与横结肠造口的效果比较 被引量:14
14
作者 朱平 朱剑飞 +2 位作者 朱俊强 石骏 张京平 《实用临床医药杂志》 CAS 2014年第1期56-57,65,共3页
目的比较预防性回肠末端造口及横结肠造口的优缺点。方法回顾性分析66例造口患者的临床资料,比较回肠造口与传统横结肠造口的切口长度、手术时间、恢复经口进食所需的时间、造口首次排便的时间及术后排泄量等指标。结果回肠造口手术的... 目的比较预防性回肠末端造口及横结肠造口的优缺点。方法回顾性分析66例造口患者的临床资料,比较回肠造口与传统横结肠造口的切口长度、手术时间、恢复经口进食所需的时间、造口首次排便的时间及术后排泄量等指标。结果回肠造口手术的切口长度为(4.2±1.5)cm,手术时间为(21.4±11.3)min;横结肠造口切口长度为(7.1±2.4)cm,手术时间为(45.5±24.8)min。回肠造口患者恢复经口进食是(1.14±0.56)d,首次经造口排便时间是(0.95±1.1)d;横结肠造口患者恢复经口进食是(3.45±1.87)d,首次排气时间是(3.87±1.5)d。结论在无大量粪便潴留的前提下,预防性回肠末端造口效果优于传统横结肠造口。 展开更多
关键词 预防性 回肠末端造口 横结肠造口
下载PDF
利福昔明乳房注入剂对干奶期奶牛临床型乳房炎预防效果观察 被引量:13
15
作者 郭旭 李培锋 +8 位作者 关红 刘明强 赵俊利 李志芳 丁月霞 史林凯 刘倩 陈少博 杨洋 《动物医学进展》 CSCD 北大核心 2013年第7期115-120,共6页
本试验旨在观察利福昔明乳房注入剂对干奶期奶牛临床性乳房炎的预防效果。选择非临床型乳房炎的泌乳末期健康奶牛共计75头,随机分为空白对照组(不给药对照组),苄星氯唑西林乳房注入剂对照组(600mg/乳区),利福昔明高(400mg/乳区)、中(200... 本试验旨在观察利福昔明乳房注入剂对干奶期奶牛临床性乳房炎的预防效果。选择非临床型乳房炎的泌乳末期健康奶牛共计75头,随机分为空白对照组(不给药对照组),苄星氯唑西林乳房注入剂对照组(600mg/乳区),利福昔明高(400mg/乳区)、中(200mg/乳区)、低(100mg/乳区)三个剂量组,每组15头。分别在干乳期、泌乳期进行乳房观察,并采用致病菌的分离培养和乳汁中体细胞计数检测临床型乳房炎发生情况。结果表明,利福昔明低剂量组保护率与空白对照组保护率相比差异显著(P<0.05),苄星氯唑西林对照组、利福昔明中剂量组、高剂量组对干奶期奶牛临床型乳房炎的预防效果与空白对照组相比,差异极显著(P<0.01);利福昔明高、中剂量组与苄星氯唑西林对照组之间的预防效果差异不显著(P>0.05)。结果提示,利福昔明乳房注入剂对临床型奶牛乳房炎有较好的预防效果,可以作为预防类药物用于奶牛生产中,降低奶牛乳房炎的发生率。 展开更多
关键词 利福昔明 临床型乳房炎 预防 奶牛
下载PDF
Values,properties and utility of different parts of Moringa oleifera:An overview 被引量:10
16
作者 Yang Liu Xiao-yue Wang +2 位作者 Xue-min Wei Zi-tong Gao Jian-ping Han 《Chinese Herbal Medicines》 CAS 2018年第4期371-378,共8页
Moringa oleifera is one of the most widespread species belonging to family Moringaceae. Almost each part of this tree has enormous properties in nutrition, medicine, or other industrial purposes. This review mainly in... Moringa oleifera is one of the most widespread species belonging to family Moringaceae. Almost each part of this tree has enormous properties in nutrition, medicine, or other industrial purposes. This review mainly introduces nutritional ingredients, bioactive compounds, applications, and potentials of this tree,including leaves, seeds, pods, flowers, root barks, and gum, in order to bring convenience to industries and researchers all over the world focusing on each part of this amazing plant. Moreover, the review also analyzes the current application situation of M. oleifera in China. After summarizing the recent researches of M. oleifera, we conclude that most current researches focus on the leaves and seeds of this plant, and the most concerned property of M. oleifera is the antioxidant ability. However, the molecular mechanisms under its multiple properties need further studies. 展开更多
关键词 Moringa oleifera Lam. nutritional value prophylactic property potential application
原文传递
姜黄素预防大鼠肝纤维化效果的观察 被引量:11
17
作者 舒建昌 叶国荣 +2 位作者 何雅军 吕霞 方力 《中药材》 CAS CSCD 北大核心 2006年第12期1347-1349,共3页
目的:明确姜黄素对实验性肝纤维化的预防效果。方法:以四氯化碳制作大鼠肝纤维化模型,同时按每100 g体重分别给予20 mg、10 mg、5 mg姜黄素灌胃处理,设立正常组、肝纤维化组和阳性对照组;8周后处死大鼠,取血检测血清ALT、AST、HA、PC-Ⅲ... 目的:明确姜黄素对实验性肝纤维化的预防效果。方法:以四氯化碳制作大鼠肝纤维化模型,同时按每100 g体重分别给予20 mg、10 mg、5 mg姜黄素灌胃处理,设立正常组、肝纤维化组和阳性对照组;8周后处死大鼠,取血检测血清ALT、AST、HA、PC-Ⅲ、TGF-β、TNF-α水平;肝脏组织HE及Masson染色观察病理改变,根据SSS计分系统评估肝纤维化程度。结果:姜黄素可以减少肝纤维化大鼠血清中明显升高的ALT、AST、HA、PC-Ⅲ、TGF-β、TNF-α水平,明显减轻肝纤维化程度,SSS计分在姜黄素组明显降低,接近正常(P<0.05),以上作用均随着姜黄素用量增大而加强。结论:姜黄素可以预防四氯化碳所致的大鼠肝纤维化,改善肝功能,具有一定的量效关系。 展开更多
关键词 姜黄素 肝纤维化 病理 预防
下载PDF
预防性宫颈环扎术治疗宫颈机能不全疗效观察 被引量:12
18
作者 霍雷 张秀丽 +1 位作者 陈银凤 梁佩丽 《海南医学》 CAS 2017年第7期1082-1084,共3页
目的观察预防性宫颈环扎术在宫颈机能不全(CIC)患者中的应用效果。方法选取2012年9月至2015年8月期间深圳龙岗区妇幼保健院妇产科收治的134例CIC患者,以数字表法随机分为观察组和对照组,每组67例,观察组给予预防性宫颈环扎术治疗,对照... 目的观察预防性宫颈环扎术在宫颈机能不全(CIC)患者中的应用效果。方法选取2012年9月至2015年8月期间深圳龙岗区妇幼保健院妇产科收治的134例CIC患者,以数字表法随机分为观察组和对照组,每组67例,观察组给予预防性宫颈环扎术治疗,对照组给予期待疗法,所有患者均随访至妊娠结束,比较两组患者的足月产率、流产率、早产率、新生儿存活率以及延长妊娠时间,同时对比不同时机宫颈环扎术对足月产率、流产率、早产率、新生儿存活率的影响。结果观察组患者的足月产率、新生儿存活率分别为67.2%和95.5%,均显著高于对照组的10.4%和58.2%,妊娠延长时间为(14.2±3.4)周,显著长于对照组的(7.3±3.2)周,差异均有显著统计学意义(P<0.01);观察组患者的流产率、早产率分别为1.5%和31.3%,均明显低于对照组的41.8%和47.8%,差异均有统计学意义(P<0.05或0.01);观察组患者孕12~16周接受宫颈环扎术患者足月产率为86.4%,明显高于17~23周的57.8%,早产率为13.6%,明显低于17~23周的40.0%,差异均有统计学意义(P<0.05)。结论预防性宫颈环扎术用于CIC患者能够有效延长妊娠时间,提高足月产率与新生儿存活率,降低流产率与早产率,提高人口质量,且该手术早期实施效果更佳。 展开更多
关键词 预防 宫颈环扎术 宫颈机能不全 疗效
下载PDF
预防性应用抗生素对肝硬化合并上消化道出血患者的影响 被引量:12
19
作者 郭月平 崔巍 《医学研究杂志》 2017年第9期115-119,145,共6页
目的探索肝硬化合并上消化道出血的患者是否需要按照Child-Pugh分数及肝硬化病因进行分层分析来评估预防性应用抗生素对医院感染率、6周再出血率及病死率的影响,探索各Child-Pugh分级及不同肝硬化病因的患者是否都需要预防性应用抗生素... 目的探索肝硬化合并上消化道出血的患者是否需要按照Child-Pugh分数及肝硬化病因进行分层分析来评估预防性应用抗生素对医院感染率、6周再出血率及病死率的影响,探索各Child-Pugh分级及不同肝硬化病因的患者是否都需要预防性应用抗生素。方法收集该类患者316例,按入院时是否预防性应用抗生素分为抗生素组与对照组,监测两组患者医院感染率、6周再出血率及病死率。结果 (1)抗生素组患者的感染率及6周再出血率更低;(2)按肝硬化病因将患者分为肝炎后肝硬化、酒精性肝硬化,结果发现,肝炎后肝硬化合并上消化道出血的患者抗生素组的感染率及6周再出血率更低;酒精性肝硬化合并上消化道出血的患者抗生素组的感染率及6周再出血率更低;(3)按Child-Pugh分级将患者分为A、B、C 3级,结果发现,Child-pugh A级的患者抗生素组与对照组感染率、6周再出血率及病死率比较,差异均无统计学意义(P>0.05);Child-pugh B级的患者抗生素组的感染率、6周再出血率更低;Child-pugh C级的患者抗生素组感染率、6周再出血率更低。结论肝硬化合并上消化道出血的患者预防性应用抗生素能降低患者的医院感染率及6周再出血率,建议此类患者入院时短期预防性应用抗生素;预防性应用抗生素的效果与肝硬化的病因无关,但与Child-Pugh分级有关,Child A级的患者医院感染率及6周再出血率、病死率均较低,预防性应用抗生素不能降低医院感染率改善患者预后,此类患者是否需要预防性应用抗生素需要进一步的研究。 展开更多
关键词 肝硬化合并上消化道出血 医院感染 预防性 抗生素
下载PDF
秋水仙碱预防肝纤维化作用的观察 被引量:10
20
作者 何雅军 舒建昌 +1 位作者 吕霞 方力 《广东药学院学报》 CAS 2006年第2期168-170,共3页
目的观察秋水仙碱预防肝纤维化的作用。方法大鼠腹腔注射CC l48周制作肝纤维化模型,同时给予秋水仙碱,8周后检测血清学指标ALT、AST、HA、PC-Ⅲ、TGFβ-、TNF-α;取肝脏组织行HE及M asson染色观察肝脏病理改变并行SSS计分评估肝纤维化... 目的观察秋水仙碱预防肝纤维化的作用。方法大鼠腹腔注射CC l48周制作肝纤维化模型,同时给予秋水仙碱,8周后检测血清学指标ALT、AST、HA、PC-Ⅲ、TGFβ-、TNF-α;取肝脏组织行HE及M asson染色观察肝脏病理改变并行SSS计分评估肝纤维化程度。结果秋水仙碱可以明显降低肝纤维化异常升高的血清指标ALT、AST、HA、PC-Ⅲ、TGFβ-、TNF-α等(P<0.05),减轻肝纤维化程度(P<0.05)。结论秋水仙碱具有预防CC l4所致肝纤维化的作用。 展开更多
关键词 秋水仙碱 肝纤维化 预防
下载PDF
上一页 1 2 70 下一页 到第
使用帮助 返回顶部